4
Changes in Ownership
Design Therapeutics, Inc. Filed Acc 0001209191-21-024224
Director bought 700,000 shares at $20.00 ($14,000,000)
- Director acquired 2,032,501 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| William Arsani Director | 2021-03-30 | Conversion | +1,217,627 | 1,217,627 | I: show line 1 in the form | ||
| William Arsani Director | 2021-03-30 | Conversion | +814,874 | 2,032,501 | I: show line 2 in the form | ||
| William Arsani Director | 2021-03-30 | Purchase | +700,000 | $20.00 | $14,000,000 | 2,732,501 | I: show line 3 in the form |
| Open-market purchases · 700,000 sh · avg $20.00 · $14,000,000 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| William Arsani Director | 2021-03-30 | Conversion · Series B Preferred Stock | −1,984,733 | 0 | I: show line 4 in the form | ||
| William Arsani Director | 2021-03-30 | Conversion · Series B Preferred Stock | −1,328,245 | 0 | I: show line 5 in the form |
Loading xslF345X03/doc4.xml…